What belongs in the first market map
| Map layer | What to capture | Why it matters |
|---|---|---|
| Current alternative | What the buyer does now if they do not buy this product. | This is often the real competitor in a first sales conversation. |
| FDA public comparator records | 510(k), De Novo, Premarket Approval (PMA), product-code, and classification clues where relevant. | These records anchor the market story in traceable public evidence. |
| Same/different matrix | Use case, technology, user, setting, workflow, claims, and support burden. | This prevents the team from treating every similar-looking record as the same competitor. |
| Customer questions | What the buyer, user, distributor, investor, or support team is likely to ask. | These questions become sales and support material. |
| Open evidence gaps | What public records do not show and what internal or customer-owned evidence is needed. | This keeps the team from overselling what public research can prove. |
What not to infer from public databases
FDA public records can help identify product categories and public device histories. They usually cannot tell you which products are actively selling, which customers prefer them, what revenue they produce, or what a buyer will adopt.
A credible market-research page should say that clearly. The value is a traceable competitor and alternative map, not a fake certainty layer.
How the map feeds sales material
- Buyer one-pager: explain the current alternative and why this product is different.
- Distributor handoff: give partners a controlled same/different comparison and do-not-say boundary.
- Training outline: prepare the workflow differences users will need to understand.
- Support frequently asked questions (FAQ): prepare the likely confusion points.
- Investor or board memo: show public evidence, market assumptions, unanswered questions, and next validation steps.
What TrueMedDevice can prepare
TrueMedDevice can prepare a product-specific market and comparator context map from FDA public records, product-code clusters, current alternatives, source links, buyer questions, and claim-boundary notes.
Source ledger
What it can tell you
FDA lists public database families for 510(k), Premarket Approval, De Novo, Product Classification, Total Product Life Cycle (TPLC), recalls, and other device records.
What it cannot decide
Market size, revenue, customer demand, competitor strength, purchasing likelihood, or sales readiness.
What it can tell you
Public product-code, generic-category, class, regulation, and medical-specialty clues that can organize competitor buckets.
What it cannot decide
Which products are true commercial competitors or how customers will compare them.
What it can tell you
Public releasable 510(k) records that may show cleared devices, applicants, product codes, and decision dates.
What it cannot decide
Whether a cleared product is a direct competitor, active seller, successful product, or relevant customer alternative.
What it can tell you
FDA points to public information about certain device approvals, clearances, and authorizations.
What it cannot decide
A company's market-entry strategy, pricing, reimbursement, adoption probability, or investor narrative.
Frequently asked questions
Is this a full market-size report?
No. The first useful deliverable is a competitor and current-alternative map. Market sizing may be a later research layer, but the first sales-readiness problem is knowing what a buyer will compare you against.
Can FDA records show who my competitors are?
They can show public device records and product-code clusters that may be relevant. They do not prove that a product is an active, direct, or commercially successful competitor.
Why connect market research to sales and support material?
Because customer questions come from comparison. A market map helps prepare the buyer story, distributor handoff, training outline, support answers, and investor narrative before those questions arrive.
Need a market map that becomes usable sales material?
Use the Market-Ready Sales & Support checklist to turn public comparator records, current alternatives, and buyer questions into one product-specific map.